U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 205039

RIFAMPIN (RIFAMPIN)
600MG/VIAL
Marketing Status: Prescription
Active Ingredient: RIFAMPIN
Proprietary Name: RIFAMPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 600MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A205039
Product Number: 001
Approval Date: Mar 3, 2016
Applicant Holder Full Name: HIKMA PHARMACEUTICALS
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top